The Association between Colonization with Carbapenemase-Producing Enterobacteriaceae and Overall ICU Mortality: An Observational Cohort Study

Critical Care Medicine

Volumn 43, Issue 6, 2015, Pages 1170-1177

  Dautzenberg, Mirjam J D ^a   Wekesa, Ann N ^a   Gniadkowski, Marek ^b   Antoniadou, Anastasia ^c   Giamarellou, Helen ^c   Petrikkos, George L ^d   Skiada, Annac ^d   Brun Buisson, Christian ^e   Bonten, Marc J M ^a   Derde, Lennie P G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

carbapenemase; Enterobacteriaceae; intensive care units; Klebsiella pneumonia; mortality; proportional hazards models

Indexed keywords

BACTERIAL ENZYME; CARBAPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE; BACTERIAL PROTEIN; BETA LACTAMASE;

ADULT; AGED; APACHE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE INFECTION; CITROBACTER FREUNDII; COHORT ANALYSIS; CONFERENCE PAPER; CRITICALLY ILL PATIENT; ENDEMIC DISEASE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ENZYME ASSAY; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; POST HOC ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEUS MIRABILIS; PROVIDENCIA STUARTII; AGE; CONTROLLED STUDY; CRITICAL ILLNESS; CROSS INFECTION; DIAGNOSIS; ENTEROBACTERIACEAE; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PERINEUM; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; APACHE; BACTERIAL PROTEINS; BETA-LACTAMASES; CARRIER STATE; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PERINEUM; PHENOTYPE; POLYMERASE CHAIN REACTION; RISK FACTORS; SEX FACTORS;

EID: 84937548487     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001028     Document Type: Conference Paper

References (38)

1. Gupta N, Limbago BM, Patel JB, et al: Carbapenem-resistant Enterobacteriaceae: Epidemiology and prevention. Clin Infect Dis 2011; 53:60-67
2. Walsh TR: Emerging carbapenemases: A global perspective. Int J Antimicrob Agents 2010; 36(Suppl 3):S8-S14
3. Munoz-Price LS, Poirel L, Bonomo RA, et al: Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785-796
4. Nordmann P, Naas T, Poirel L: Global spread of carbapenemase-pro-ducing Enterobacteriaceae. Emerg Infect Dis 2011; 17:1791-1798
5. Nordmann P, Poirel L: The diffcult-to-control spread of carbapen-emase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 2014; 20:821-830
6. Nordmann P, Gniadkowski M, Giske CG, et al; European Network on Carbapenemases: Identification and screening of carbapene-mase-producing Enterobacteriaceae. Clin Microbiol Infect 2012; 18:432-438
7. Nordmann P, Cuzon G, Naas T: The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9:228-236
8. Derde LP, Cooper BS, Goossens H, et al; MOSAR WP3 Study Team: Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: An interrupted time series study and cluster randomised trial. Lancet Infect Dis 2014; 14:31-39
9. Qureshi ZA, Paterson DL, Potoski BA, et al: Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: Superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012; 56:2108-2113
10. Gasink LB, Edelstein PH, Lautenbach E, et al: Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K pneumoniae. Infect Control Hosp Epidemiol 2009; 30:1180-1185
11. Marchaim D, Navon-Venezia S, Schwaber MJ, et al: Isolation of imipe-nem-resistant Enterobacter species: Emergence of KPC-2 carbapen-emase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008; 52:1413-1418
12. Patel G, Huprikar S, Factor SH, et al: Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29:1099-1106
13. Kofteridis DP, Valachis A, Dimopoulou D, et al: Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: A case-case-control study. J Infect Chemother 2014; 20:293-297
14. Lai CC, Wu UI, Wang JT, et al: Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan. J Formos Med Assoc 2013; 112:492-496
15. Schwaber MJ, Klarfield-Lidji S, Navon-Venezia S, et al: Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52:1028-1033
16. Souli M, Galani I, Antoniadou A, et al: An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: Molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010; 50:364-373
17. Lortholary O, Fagon JY, Hoi AB, et al: Nosocomial acquisition of mul-tiresistant Acinetobacter baumannii: Risk factors and prognosis. Clin Infect Dis 1995; 20:790-796
18. Maragakis LL, Perl TM: Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46:1254-1263
19. Gazin M, Paasch F, Goossens H, et al; MOSAR WP2 and SATURN WP1 Study Teams: Current trends in culture-based and molecular detection of extended-spectrum-lactamase-harboring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 2012; 50:1140-1146
20. Gazin M, Lammens C, Derde LPG, et al: External Quality Assessment of Culture-Based Detection of Extended Spectrum Beta Lactamase Producing Gram-Negative Bacteria by a Network of European Laboratories. London, ECCMID, 2012
21. Fiett J, Baraniak A, Mrówka A, et al: Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland. Antimicrob Agents Chemother 2006; 50:880-886
22. Mushtaq S, Irfan S, Sarma JB, et al: Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother 2011; 66:2002-2005
23. Navon-Venezia S, Chmelnitsky I, Leavitt A, et al: Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbape-nem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006; 50:3098-3101
24. Poirel L, Héritier C, Tolün V, et al: Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48:15-22
25. Beyersmann J, Schumacher M: Time-dependent covariates in the proportional subdistribution hazards model for competing risks. Biostatistics 2008; 9:765-776
26. Beyersmann J, Allignol A, Schumacher M: Competing Risks and Multistate Models With R. New York, Springer, 2008
27. Wolkewitz M, Vonberg RP, Grundmann H, et al: Risk factors for the development of nosocomial pneumonia and mortality on intensive care units: Application of competing risks models. Crit Care 2008; 12:R44
28. Beyersmann J, Gastmeier P, Wolkewitz M, et al: An easy mathematical proof showed that time-dependent bias inevitably leads to biased effect estimation. J Clin Epidemiol 2008; 61:1216-1221
29. Beyersmann J, Wolkewitz M, Schumacher M: The impact of time-dependent bias in proportional hazards modelling. Stat Med 2008; 27:6439-6454
30. Lau B, Cole SR, Gange SJ: Competing risk regression models for epidemiologic data. Am J Epidemiol 2009; 170:244-256
31. Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al: KPC producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: The signifcance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 2013; 77:169-173
32. Debby BD, Ganor O, Yasmin M, et al: Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit. Eur J Clin Microbiol Infect Dis 2012; 31:1811-1817
33. Eachempati SR, Hydo L, Barie PS: Gender-based differences in outcome in patients with sepsis. Arch Surg 1999; 134:1342-1347
34. Nachtigall I, Tafelski S, Rothbart A, et al: Gender-related outcome difference is related to course of sepsis on mixed ICUs: A prospective, observational clinical study. Crit Care 2011; 15:R151
35. Combes A, Luyt CE, Trouillet JL, et al: Gender impact on the outcomes of critically ill patients with nosocomial infections. Crit Care Med 2009; 37:2506-2511
36. Adrie C, Azoulay E, Francais A, et al; OutcomeRea Study Group: Influence of gender on the outcome of severe sepsis: A reappraisal. Chest 2007; 132:1786-1793
37. Epstein SK, Vuong V: Lack of Influence of gender on outcomes of mechanically ventilated medical ICU patients. Chest 1999; 116:732-739
38. Voulgari E, Zarkotou O, Ranellou K, et al: Outbreak of OXA-48 car-bapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother 2013; 68:84-88